US Patent Issued to Henan Zhiwei Biomedicine on May 6 for "Substituted 1-amino-1H-imidazole-5-carboxamide as Bruton's tyrosine kinase inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,516, issued on May 6, was assigned to Henan Zhiwei Biomedicine Co. Ltd. (Xinxiang, China).

"Substituted 1-amino-1H-imidazole-5-carboxamide as Bruton's tyrosine kinase inhibitors" was invented by Qingjie Ding (Xinxiang, China), Chunhua Ma (Xinxiang, China), Yuqin Jiang (Xinxiang, China), Guiqing Xu (Xinxiang, China), Wei Li (Xinxiang, China), Minghao Zhao (Xinxiang, China), Qingyun Li (Xinxiang, China), Dandan Zhang (Xinxiang, China), Guojie Fan (Xinxiang, China), Yang Li (Xinxiang, China), Xin Shi (Xinxiang, China) and Shouning Yang (Xinxiang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a compound of formula I or a pharmaceutic...